The mRNA therapeutics and vaccines market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors.

This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile delivery platforms at reduced toxicity levels.

The financial opportunity within the mRNA therapeutics and mRNA vaccines market has been analyzed across the following segments:

§  Routes of Administration

§  Intradermal

§  Intravenous

§  Intranasal

§  Others

§  Therapeutic Area

§  Infectious Diseases

§  Oncological Disorders

§  Other Disorders

Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Latin America

§  Middle East and North Africa

The mRNA Therapeutics and mRNA Vaccine Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:

§  Arcturus Therapeutics

§  BioNTech and Pfizer

§  CureVac

§  Gennova

§  Moderna

§  Walvax

Table of Contents

1.         Preface

2.         Executive Summary

3.         Introduction

4.         Market Overview

5.         Competitive Landscape

6.         Company Competitiveness Analysis

7.         Drug Profiles

8.         Big Pharma Initiatives

9.          Start-Up Health Indexing

10.       Clinical Trial Analysis

11.       Partnerships and Collaborations

12.       Funding and Investment Analysis

13.       Patent Analysis

14.        Market Forecast and Opportunity Analysis

15.       Market Forecast and Opportunity Analysis

16.       Conclusion

17.       Appendix 1: Tabulated Data

18.       Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

News article

Biopharmaceutical Filtration Market

Learn from experts:  do you know about these emerging industry trends?

CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com